脉络膜血管瘤治疗的新进展

Recent progress of choroidal hemangioma

脉络膜血管瘤是一种较为少见的良性肿瘤,其病变多发生在眼底后极部,瘤体渗液及侵及黄斑区可导致视网膜脱离等并发症,造成视力损害。脉络膜血管瘤可分为孤立性脉络膜血管瘤和弥漫性脉络膜血管瘤。前者并发症较少,而后者多表现为Sturge-weber症。目前对于脉络膜血管瘤的治疗主要是通过:光凝术、放射治疗、经瞳孔温热疗法、光动力学疗法等。我们旨在介绍各种疗法的现状及最新进展,探索治疗脉络膜血管瘤的最安全有效的方法。

Choroidal hemangioma （CH） is a benign vascular tumor that occurred in the fundus posterior pole. Although it is a benign tumor, exudation from the lesion can lead to retinal detachment and other complications that make visual loss for patients. CH can occur as a circumscribed choroidal hemangioma （CCH）, generally without systemic associations, or as a diffuse choroidal hemangioma （DCH） that is often associated variations of Sturge- weber syndrome （SWS）. The management of CH has included laser photocoagulation, radiation therapy, transpupillary thermotherapy （ TTT ）, photodynamic therapy （PDT）. This article aims to introduce the current situation and the latest progress of the various therapies, to explore the most safe and effective method for the treatment of CH.